CFTR and ENaC functions in cystic fibrosis

被引:0
作者
Palma, Alejandra G. [1 ]
Kotsias, Basilio A. [1 ]
Marino, Gabriela I. [1 ]
机构
[1] Univ Buenos Aires, IDIM CONICET, Inst Invest Med Alfredo Lanari, Lab Cana Ion, Buenos Aires, DF, Argentina
关键词
cystic fibrosis; CFTR; ENaC; ionic movements; cytoskeleton; TRANSMEMBRANE CONDUCTANCE REGULATOR; GAP-JUNCTION CHANNELS; MUTATIONS; GENE; EXPRESSION; DELTA-F508; TRANSPORT; AMILORIDE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cystic fibrosis is caused by dysfunction or lack of the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that has a key role in maintaining ion and water honnoeostasis in different tissues. CFTR is a cyclic AMP-activated Cl- channel found in the apical and basal plasma membrane of airway, intestinal, and exocrine epithelial cells. One of CFTR's primary roles in the lungs is to maintain homoeostasis of the airway surface liquid layer through its function as a chloride channel and its regulation of the epithelial sodium channel ENaC. More than 1900 CFTR mutations have been identified in the cftr gene. The disease is characterized by viscous secretions of the exocrine glands in multiple organs and elevated levels of sweat sodium chloride. In cystic fibrosis, salt and fluid absorption is prevented by the loss of CFTR and ENaC is not appropriately regulated, resulting in increased fluid and sodium resorption from the airways and formation of a contracted viscous surface liquid layer. In the sweat glands both Na+ and Cl- ions are retained in the lumen, causing significant loss of electrolytes during sweating. Thus, elevated sweat NaCl concentration is the basis of the classic pilocarpine-induced sweat test as a diagnostic feature of the disease. Here we discuss the ion movement of Cl- and Na+ ions in two tissues, sweat glands and in the air surface as well as the role of ENaC in the pathogenesis of cystic fibrosis.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
[31]   Ouabain mimics low temperature rescue of F508del-CFTR in cystic fibrosis epithelial cells [J].
Zhang, Donglei ;
Ciciriello, Fabiana ;
Anjos, Suzana M. ;
Carissimo, Annamaria ;
Liao, Jie ;
Carlile, Graeme W. ;
Balghi, Haouaria ;
Robert, Renaud ;
Luini, Alberto ;
Hanrahan, John W. ;
Thomas, David Y. .
FRONTIERS IN PHARMACOLOGY, 2012, 3
[32]   Assessment of epithelial sodium channel variants in nonwhite cystic fibrosis patients with non-diagnostic CFTR genotypes [J].
Brennan, Marie-Luise ;
Pique, Lynn M. ;
Schrijver, Iris .
JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (01) :52-59
[33]   ENaC is a host susceptibility factor to bacterial infections in cystic fibrosis context [J].
Toure, Hamadoun ;
Durand, Nicolas ;
Orgeur, Mickael ;
Galindo, Lee Ann ;
Girard-Misguich, Fabienne ;
Guenal, Isabelle ;
Herrmann, Jean-Louis ;
Szuplewski, Sebastien .
COMMUNICATIONS BIOLOGY, 2025, 8 (01)
[34]   MicroRNAs and cystic fibrosis - an epigenetic perspective [J].
Xu, Wenming ;
Hui, Chen ;
Yu, Sidney Siu Bun ;
Jing, Chen ;
Chan, Hsiao Chang .
CELL BIOLOGY INTERNATIONAL, 2011, 35 (05) :463-466
[35]   The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability [J].
Meng, Xin ;
Clews, Jack ;
Kargas, Vasileios ;
Wang, Xiaomeng ;
Ford, Robert C. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (01) :23-38
[36]   Genomic, transcriptomic, and protein landscape profile of CFTR and cystic fibrosis [J].
Sanders, Morgan ;
Lawlor, James M. J. ;
Li, Xiaopeng ;
Schuen, John N. ;
Millard, Susan L. ;
Zhang, Xi ;
Buck, Leah ;
Grysko, Bethany ;
Uhl, Katie L. ;
Hinds, David ;
Stenger, Cynthia L. ;
Morris, Michele ;
Lamb, Neil ;
Levy, Hara ;
Bupp, Caleb ;
Prokop, Jeremy W. .
HUMAN GENETICS, 2021, 140 (03) :423-439
[37]   Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis [J].
Ratkiewicz, Michelle ;
Pastore, Matthew ;
McCoy, Karen Sharrock ;
Thompson, Rohan ;
Hayes, Don, Jr. ;
Sheikh, Shahid Ijaz .
WORLD JOURNAL OF PEDIATRICS, 2017, 13 (02) :129-135
[38]   CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis [J].
Lopes-Pacheco, Miqueias .
FRONTIERS IN PHARMACOLOGY, 2016, 7
[39]   CFTR High Expresser Cells in cystic fibrosis and intestinal diseases [J].
dos Reis, Diego Carlos ;
Dastoor, Parinaz ;
Santos, Anderson Kenedy ;
Sumigray, Kaelyn ;
Ameen, Nadia A. .
HELIYON, 2023, 9 (03)
[40]   CFTR modulator therapies in pediatric cystic fibrosis: focus on ivacaftor [J].
Kramer, Elizabeth L. ;
Clancy, John P. .
EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (10) :1033-1042